192 related articles for article (PubMed ID: 10795626)
1. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies.
Feo F; Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi D
Crit Rev Oncog; 2000; 11(1):19-62. PubMed ID: 10795626
[TBL] [Abstract][Full Text] [Related]
2. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
Pascale RM; Simile MM; Feo F
Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.
Feo F; Frau M; Tomasi ML; Brozzetti S; Pascale RM
Exp Biol Med (Maywood); 2009 Jul; 234(7):726-36. PubMed ID: 19429855
[TBL] [Abstract][Full Text] [Related]
4. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D
Cancer Res; 2006 Apr; 66(8):4001-10. PubMed ID: 16618719
[TBL] [Abstract][Full Text] [Related]
5. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
Herath NI; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.
Herzog CR; Lubet RA; You M
J Cell Biochem Suppl; 1997; 28-29():49-63. PubMed ID: 9589349
[TBL] [Abstract][Full Text] [Related]
7. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.
Zhao W; Liu H; Liu W; Wu Y; Chen W; Jiang B; Zhou Y; Xue R; Luo C; Wang L; Jiang JD; Liu J
Int J Oncol; 2006 May; 28(5):1081-8. PubMed ID: 16596223
[TBL] [Abstract][Full Text] [Related]
8. Genetic mechanisms of hepatocarcinogenesis.
Feitelson MA; Sun B; Satiroglu Tufan NL; Liu J; Pan J; Lian Z
Oncogene; 2002 Apr; 21(16):2593-604. PubMed ID: 11971194
[TBL] [Abstract][Full Text] [Related]
9. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
[TBL] [Abstract][Full Text] [Related]
10. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
11. Cellular and molecular mechanisms of hepatocarcinogenesis.
Rogler CE; Chisari FV
Semin Liver Dis; 1992 Aug; 12(3):265-78. PubMed ID: 1439879
[TBL] [Abstract][Full Text] [Related]
12. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
13. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of human hepatocellular carcinoma.
Thorgeirsson SS; Grisham JW
Nat Genet; 2002 Aug; 31(4):339-46. PubMed ID: 12149612
[TBL] [Abstract][Full Text] [Related]
15. Preneoplastic lesions in human hepatocarcinogenesis.
Libbrecht L; Desmet V; Roskams T
Liver Int; 2005 Feb; 25(1):16-27. PubMed ID: 15698394
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain.
De Miglio MR; Muroni MR; Simile MM; Virdis P; Asara G; Frau M; Calvisi DF; Seddaiu MA; Pascale RM; Feo F
Hepatology; 2001 May; 33(5):1110-7. PubMed ID: 11343238
[TBL] [Abstract][Full Text] [Related]
17. Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis.
De Miglio MR; Pascale RM; Simile MM; Muroni MR; Calvisi DF; Virdis P; Bosinco GM; Frau M; Seddaiu MA; Ladu S; Feo F
Cancer Res; 2002 Aug; 62(15):4459-63. PubMed ID: 12154055
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
19. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
[TBL] [Abstract][Full Text] [Related]
20. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
